Five millennia of wound care products - What is new? a literature review

Ostomy Wound Management

Volumn 55, Issue 3, 2009, Pages 16-32

  Mouës, Chantal M ^a   Heule, Freerk ^b   Legerstee, Ron ^b   Hovius, Steven E R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Systagenix Wound Management ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTISEPSIS; BANDAGE; DEBRIDEMENT; DISINFECTION; EVIDENCE BASED PRACTICE; HISTORY; HUMAN; INJURY; PRACTICE GUIDELINE; REVIEW; SKIN CARE; WOUND HEALING;

ANTI-BACTERIAL AGENTS; ANTISEPSIS; BANDAGES; DEBRIDEMENT; DISINFECTION; EVIDENCE-BASED PRACTICE; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HISTORY, MEDIEVAL; HUMANS; PRACTICE GUIDELINES AS TOPIC; SKIN CARE; WOUND HEALING; WOUNDS AND INJURIES;

EID: 67649208879     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Majno G. The Healing Hand. Man and Wound in the Ancient World. Cambridge, MA: Harvard University Press;1975.
2. Bibbings J. Honey, lizard dung and pigeons' blood. Nurs Times. 1984;80(48):36-38.
3. Dollwet HH, Sorenson JR. Roles of copper in bone maintenance and healing. Biol Trace Elem Res. 1988;18(1):39-48.
4. Caldwell MD. Topical wound therapy - an historical perspective. J Trauma. 1990;30(12 suppl):S116- S22.
5. Lansdown AB. A review of the use of silver in wound care: facts and fallacies. Br J Nurs. 2004;13(6 suppl):S6-S19.
6. Aldini N, Fini M, Giardino R. From Hippocrates to tissue engineering: surgical strategies in wound treatment. World J Surg. 2008;32(9):2114-2121.
7. Bolton LL. Moist wound healing from past to present. In: Rovee DT, Maibach HI (eds). The Epidermis in Wound Healing. London, UK: CRC Press;2004:89-101.
8. Lee YL, Cesario T, Wang Y, Shanbrom E, Thrupp L. Antibacterial activity of vegetables and juices. Nutrition. 2003;19(11 -12):994-996.
9. Giner-Larza EM, Manez S, Giner RM, et al. Anti-inflammatory triterpenes from Pistacia terebinthus galls. Planta Med. 2002;68(4):311-315.
10. Selvaggi G, Monstrey S, Van Landuyt K, Hamdi M, Blondeel P. The role of iodine in antisepsis and wound management: a reappraisal. Acta Chir Belg. 2003;103(3):241-247.
11. Gamgee S. The treatment of wounds. Lancet. 1876;108(1282):885-887.
12. Haller JS Jr. Treatment of infected wounds during the Great War, 1914 to 1918. South Med J. 1992;85(3):303-315.
13. Forrest RD. Early history of wound treatment. J R Soc Med. 1982;75(3):198-205.
14. Saadia R, Schein M. Debridement of gunshot wounds: semantics and surgery. World J Surg. 2000;24(9):1146-1149.
15. Coppi C. I dressed your wounds, God healed you. A wounded person's psychology according to Ambroise Pare. Ostomy Wound Manage. 2005;51(8):62-64.
16. Klasen HJ. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns. 2000;26(2):117-130.
17. Carrel A, Burrows M. Cultivation of adult tissues and organs outside the body. JAMA. 1910;55:1379- 1381.
18. Reverdin J. Greffe epidermique. Bull Soc Imperiale Chir Paris. 1869;10:511-515.
19. Chick LR: Brief history and biology of skin grafting. Ann Plast Surg. 1988;21(4):358-365.
20. Freshwater MF, Krizek TJ. George David Pollock and the development of skin grafting. Ann Plast Surg. 1978;1(1):96-102.
21. Kramer-Schultheiss KS, Schultheiss D. From wound healing to modern tissue engineering of the skin. A historical review on early techniques of cell and tissue culture. Hautarzt. 2002;53(11 ):751-760.
22. Moulin de D. A History of Surgery: with Emphasis on the Netherlands. Dordrecht: Martinus Nijhoff Publishers;1988.
23. Illingworth C. The Lister Lecture, 1964: Wound Sepsis - from Carbolic Acid to Hyperbaric Oxygen. Can Med Assoc J. 1964;91 (20):1041-1045.
24. Drosou A, Falabella A, Kirsner RS. Antiseptics on wounds: an area of controversy. WOUNDS. 2003;15(5):149-166.
25. Flynn J. Povidone-iodine as a topical antiseptic for treating and preventing wound infection: a literature review. Br J Community Nurs. 2003;8(6 suppl):S36-S42.
26. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns. 2000;26(2):131-138.
27. Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW Jr. Treatment of large human burns with 0.5 per cent silver nitrate solution. Arch Surg. 1965;90(6):812-867.
28. Russell A. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol. 2002;92(suppl):121S- 35S.
29. Lineaweaver W, McMorris S, Soucy D, Howard R. Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg. 1985;75(3):394-396.
30. Lineaweaver W, Howard R, Soucy D, et al. Topical antimicrobial toxicity. Arch Surg. 1985;120(3):267- 270.
31. Cooper ML, Laxer JA, Hansbrough JF. The cytotoxic effects of commonly used topical antimicrobial agents on human fibroblasts and keratinocytes. J Trauma. 1991 ;31(6):775-782; discussion 782-784.
32. Larson EL, McGinley KJ, Foglia AR, Talbot GH, Leyden JJ. Composition and antimicrobic resistance of skin flora in hospitalized and healthy adults. J Clin Microbiol. 1986;23(3):604-608.
33. Lawrence JC. The use of iodine as an antiseptic agent. J Wound Care. 1998;7(8):421-425.
34. Fox CL Jr. Topical therapy and the development of silver sulfadiazine. Surg Gynecol Obstet. 1983;157(1):82-88.
35. Bang LM, Buntting C, Molan P. The effect of dilution on the rate of hydrogen peroxide production in honey and its implications for wound healing. J Altern Complement Med. 2003;9(2):267-273.
36. Cooper RA, Molan PC, Harding KG. The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol. 2002;93(5):857-863.
37. Cooper RA, Halas E, Molan PC. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J Burn Care Rehabil. 2002;23(6):366-370.
38. Efem SE, Udoh KT, Iwara CI. The antimicrobial spectrum of honey and its clinical significance. Infection. 1992;20(4):227-229.
39. Lusby PE, Coombes A, Wilkinson JM. Honey: a potent agent for wound healing? J WOCN. 2002;29(6):295-300.
40. White JW Jr, Subers MH, Schepartz AI. The identification of inhibine, the antibacterial factor in honey, as hydrogen peroxide and its origin in a honey glucose-oxidase system. Biochim Biophys Acta. 1963;73(5):57-70.
41. Willix DJ, Molan PC, Harfoot CG. A comparison of the sensitivity of wound-infecting species of bacteria to the antibacterial activity of Manuka honey and other honey. J Appl Bacteriol. 1992;73(5):388-394.
42. Molan PC. The role of honey in the management of wounds. J Wound Care. 1999;8(8):415-418.
43. Pieper B, Caliri MH. Nontraditional wound care: a review of the evidence for the use of sugar, papaya/papain, and fatty acids. J WOCN. 2003;30(4):175-183.
44. Dawson JS. Preiskel Elective Prize. The role of sugar in wound healing. A comparative trial of the healing of infected wounds using traditional gauze/antiseptic packing, and granulated sugar, undertaken during an elective period at Kagando Hospital, Uganda. Ann R Coll Surg Engl. 1996;78(2 suppl):82-85.
45. Goldstein H. Maggots in the treatment of wound and bone infections. J Bone Joint Surg. 1931;13(3):476-478.
46. Bear W. The treatment of chronic osteomyelitis with the maggot (larva of the blowfly). J Bone Joint Surg. 1931;13:438-475.
47. Lerch K, Linde HJ, Lehn N, Grifka J. Bacteria ingestion by blowfly larvae: an in vitro study. Dermatology. 2003;207(4):362-366.
48. Horobin AJ, Shakesheff KM, Woodrow S, Robinson C, Pritchard DI. Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol. 2003;148(5):923-933.
49. Sherman RA, Hall MJ, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol. 2000;45(1):55-81.
50. Steenvoorde P, Jukema GN. The antimicrobial activity of maggots: in vivo results. J Tissue Viabil. 2004;14(3):97-101.
51. Winter GD. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature. 1962;193:293-294.
52. Hinman CD, Maibach H. Effect of air exposure and occlusion on experimental human skin wounds. Nature. 1963;200(10):377-378.
53. Garb J. Nevus verrucosus unilateris cured with podophyllin ointment. Ointment applied as occlusive dressings: report of a case. Arch Dermatol. 1960;81(4):606-609.
54. Jonkman MF. Occlusive dressings. Ned Tijdschr Geneeskd. 1991;135(41):1905-1908.
55. Kester J, Fennema O. Edible films and coatings: a review. Food Technology. 1986;12(40):47-59.
56. Morgan D. Alginate dressings. J Tissue Viabil. 1996;7(1):4-14.
57. Chaby G, Senet P, Vaneau M, et al. Dressings for acute and chronic wounds: a systematic review. Arch Dermatol. 2007;143(10):1297-1304.
58. Vaneau M, Chaby G, Guillot B, et al. Consensus panel recommendations for chronic and acute wound dressings. Arch Dermatol. 2007;143(10):1291-1294.
59. Falanga V, Grinnell F, Gilchrest B, Maddox YT, Moshell A. Workshop on the pathogenesis of chronic wounds. J Invest Dermatol. 1994; 102(1 ):125-127.
60. Bakker K, Schaper NC: New developments in the treatment of diabetic foot ulcers. Ned Tijdschr Geneeskd. 2000;144(9):409-412.
61. Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986;204(3):322-330.
62. Robson MC, Phillips LG, Thomason A, Robson LE, Pierce GF. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet. 1992;339(8784):23-25.
63. Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care. 1998;21(5):822-827.
64. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg. 1995;21 (1 ):71-78; discussion 7981.
65. Smiell JM. Clinical safety of becaplermin (rhPDGF-BB) gel. Becaplermin Studies Group. Am J Surg. 1998;176(2A suppl): 68S-73S.
66. US Food and Drug Administration. rhPDGF. Available at: www.fda.gov/cder/drug. Accessed February 21, 2009.
67. Badiavas E, Mehta PP, Falanga V. Retrovirally mediated gene transfer in a skin equivalent model of chronic wounds. J Dermatol Sci. 1996;13(1):56-62.
68. Robson MC, Cooper DM, Aslam R, et al. Guidelines for the treatment of venous ulcers. Wound Repair Regen. 2006;14(6):649-662.
69. Vin F, Teot L, Meaume S. The healing properties of Promogran in venous leg ulcers. J Wound Care. 2002;11(9):335-341.
70. Eaglstein WH, Falanga V. Tissue engineering for skin: an update. J Am Acad Dermatol. 1998;39(6):1007-1010.
71. Eaglstein WH, Falanga V. Tissue engineering and the development of Apligraf a human skin equivalent. Adv Wound Care. 1998;11 (4 suppl):1-8.
72. Steed DL, Attinger C, Colaizzi T, et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen. 2006;14(6):680-692.
73. Blakytny R, Jude EB, Martin Gibson J, Boulton AJ, Ferguson MW. Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol. 2000;190(5):589-594.
74. Andreadis ST. Gene transfer to epidermal stem cells: implications for tissue engineering. Expert Opin Biol Ther. 2004;4(6):783-800.
75. Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol. 2003;139(4):510-516.
76. Cherry GW, Harding K, Ryan TJ. Wound Bed Preparation. International Congress and Symposium Series 250. London, UK: Roy Soc Med Press Ltd;2001.
77. Schultz GS, Sibbald RG, Falanga V, et al. Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11 (1 suppl):S1-S28.
78. Attinger CE, Bulan EJ. Debridement. The key initial first step in wound healing. Foot Ankle Clin. 2001 ;6(4):627-660.
79. Mouës CM, van den Bemd GJCM, Hovious SER. Debridement of chronic wounds temporarily induces an acute-like environment that stimulates fibroblasts. Wound Repair Regen. 2004;11(5):A30.
80. Cook H, Davies KJ, Harding KG, Thomas DW. Defective extracellular matrix reorganization by chronic wound fibroblasts is associated with alterations in TIMP-1, TIMP-2, and MMP-2 activity. J Invest Dermatol. 2000;115(2):225-233.
81. Mouës CM, Vos MC, van den Bemd GJ, Stijnen T, Hovius SE. Bacterial load in relation to vacuum- assisted closure wound therapy: a prospective randomized trial. Wound Repair Regen. 2004;12(1):11-17.
82. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997;38(6):553-562.
83. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997;38(6):563-576; discussion 577.
84. Redon H. Closing of large wounds by suppression. Presse Med. 1955;63(49):1034.
85. Kostiuchenok BM, Kolker, II, Karlov VA, Ignatenko SN, Muzykant LI. Vacuum treatment in the surgical management of suppurative wounds. Vestn Khir Im I I Grek. 1986;137(9):18-21.
86. Usupov Y, Yepifanov M. Active wound drainage. Vestnik Khirugii. 1987;4:42-45.
87. Chariker M, Jeter K, Tintle T. Effective management of incisional and cutaneous fistulae with closed suction wound drainage. Contemp Surg. 1989;34:59-63.
88. Fleischmann W, Lang E, Russ M. Treatment of infection by vacuum sealing. Unfallchirurg. 1997;100(4):301-304.
89. Fleischmann W, Russ M, Westhauser A, Stampehl M. Vacuum sealing as carrier system for controlled local drug administration in wound infection. Unfallchirurg. 1998;101(8):649-654.
90. Fleischmann W, Strecker W, Bombelli M, Kinzl L. Vacuum sealing as treatment of soft tissue damage in open fractures. Unfallchirurg. 1993;96(9):488-492.
91. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005;366(9498):1704-1710.
92. Vuerstaek JD, Vainas T, Wuite J, Nelemans P, Neumann MH, Veraart JC. State-of-the-art treatment of chronic leg ulcers: a randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. J Vasc Surg. 2006;44(5):1029-1037; discussion 1038.
93. Saxena V, Hwang CW, Huang S, Eichbaum Q, Ingber D, Orgill DP. Vacuum-assisted closure: microdeformations of wounds and cell proliferation. Plast Reconstr Surg. 2004;114(5):1086-96; discussion 1097-1098.
94. Timmers MS, Le Cessie S, Banwell P, Jukema GN. The effects of varying degrees of pressure delivered by negative-pressure wound therapy on skin perfusion. Ann Plast Surg. 2005;55(6): 665-671.
95. World Union of Wound Healing Societies (WUWHS). Principles of best practice: vacuum assisted closure: recommendations for use. A consensus document. Available at: www.WUWHS.org. Accessed February 22, 2009.
96. Berendt AR. Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective. Clin Infect Dis. 2006;43(2):193-198.
97. Barnes RC. Point: hyperbaric oxygen is beneficial for diabetic foot wounds. Clin Infect Dis. 2006;43(2):188-192.
98. Sheridan RL, Shank ES. Hyperbaric oxygen treatment: a brief overview9of a controversial topic. J Trauma. 1999;47(2):426-435.
99. Roeckl-Wiedmann I, Bennett M, Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg. 2005;92(1):24-32.
100. Weiss DS, Kirsner R, Eaglstein WH. Electrical stimulation and wound healing. Arch Dermatol. 1990;126(2):222-225.
101. Hampton S, King L. Healing an intractable wound using bio-electrical stimulation therapy. Br J Nurs. 2005;14(15):S30-S32.
102. Gordon GA. Designed electromagnetic pulsed therapy: clinical applications. J Cell Physiol. 2007;212(3):579-582.
103. Ennis WJ, Meneses P, Borhani M. Push-pull theory: using mechanotransduction to achieve tissue perfusion and wound healing in complex cases. Gynecol Oncol. 2008;111 (2 suppl): S81-S86.